CFO was right, that $39 is the best place to sell as the stock now drops into the $36 range.
Careful, independent thinking like that will get you labeled a whinebag by Gary the blind-faith-follower.
If I sold today, lost money, can I make it up on volume?
HEY, maybe I can be CFO.
You can force shareholder on this message board's head under water but you can't make them resist it.
I guess they like abuse and torture.
We will survive, but that doesn't mean taking small doses of poison is a good thing. Nor is the person good who is feeding is the poison.
I stand up for what is right. It is a shame you don't have the ethics nor backbone to do the same.
It makes sense if you don't think about it.
There you go thinking again. Shame on you. Thinking for yourself.
Just go along with the crowd and the spaceship will beam everybody up soon. The comet is coming the comet is coming.
No, whatever you do, don't think independently, and definitely don't remember what they told you before.
No actually, this part of the management team that couldn't get anything right with the FDA. Mahatme was by Garabedian's side during all the turmoil. Kaye is the solution, Mahatme is part of the problem.
If drug approval was imminent, wouldn't they get a much higher price per share?
Why would they not go for the much higher price per share?
Why rush for the lower value that would further lower the share price?
Why rush to hurt shareholders?
It doesn't make sense if things were on track for drug approval.
It's all good? That explains your D- in math. The basic principle of compounding shows that this dilution goes on for eternity. It isn't "good" unless they aren't going to get approval by the FDA. Only then would it be considered a good thing.
Or maybe the FDA whispered in their ear that they weren't going to get approval, and better raise the cash now while they can? I hope that is not the case, but that is the only scenario I can think of that would warrant this kind of a stupid move.
You can hire my dog for 1/10th of what the CFO makes. To call the CFO a dog would be an insult to dogs everywhere.
Seriously, why the hell are we paying a CFO more than HALF A MILLION DOLLARS A YEAR if he can't figure out anything better than a secondary offering. A High School dropout can do that, and they sure as hell wouldn't do it during a market meltdown that is still in correction.
The strategy works. Promise stupid people you will give them free stuff and they will vote for you, and because they are stupid they never follow up.
Everything still looks good in INCY as far as I can see. Lots of good biotechs getting hit today including ISIS (who has probably the richest pipeline of any biotech), SCMP (a cash cow), INSY, RDUS, and many others that are down 5% for no reason other than funds getting calls from a small percentage of investors to pull money out, so the fund must liquidate holdings across the board.
From everything I see, INCY looks rock solid for the future, and this is nothing more than a buying opportunity. By the end of the month we should be back up over $130 easily.